[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0

Sharma, V and Tewari, R and Ugir Hossain, SK and Joseph, C and Sen, Ellora (2008) Ebselen sensitizes glioblastoma cells to Tumor Necrosis Factor (TNFalpha)-induced apoptosis through two distinct pathways involving NF-kappaB downregulation and Fas-mediated formation of death inducing signaling complex. International Journal of Cancer, 123 (9). pp. 2204-2212.

[img]
Preview
Text
ijc.23771.pdf

Download (331Kb) | Preview

Abstract

Resistance to tumor necrosis factor (TNFalpha)-induced apoptosis in various cancer cells has been attributed to the activation of the transcription factor NF-kappaB. Ebselen (2-phenyl-1,2-benzisoselenazol-3[2H]one)-a selenoorganic compound is known to prevent TNFalpha-mediated NF-kappaB activity. As glioblastoma are resistant to the cytotoxic effect of TNFalpha, we investigated the potential of Ebselen in sensitizing glioma cells to TNFalpha-induced apoptosis. Although treatment with Ebselen reduced viability of glioma cells, cotreatment with TNFalpha enhanced apoptosis further through alteration of TNFalpha-mediated signaling pathways. Sensitization of TNFalpha activated glioma cells to apoptosis by Ebselen involved 2 pathways: (i) abrogation of TNFalpha induced NF-kappaB activation and (ii) induction of Fas-associated death inducing signaling complex (DISC) formation. Ebselen inhibited the prosurvival pathway mediated by NF-kappaB by altering the association of TNF receptor associated factor 2 (TRAF2) with TNFalpha receptor associated death domain (TRADD) in the TNFR1-TRADD-TRAF2 complex -an interaction crucial for mediating NF-kappaB activity. Ebselen also induced the formation of DISC involving Fas, Fas-associated death domain (FADD) and active caspase 8 to transduce apoptotic signals in situations where NF-kappaB function was inhibited. Cotreatment with Ebselen and TNFalpha induced G2/M phase arrest in cell cycle and modulated the expression of molecules involved in cell cycle progression. These results raise the possibility of overcoming resistance to TNFalpha-induced apoptosis by cotreatment with organoselenium Ebselen as a strategy to kill glioma cells.

Item Type: Article
Subjects: Neurodegenerative Disorders
Neuro-Oncological Disorders
Neurocognitive Processes
Neuronal Development and Regeneration
Informatics and Imaging
Genetics and Molecular Biology
Depositing User: Dr. D.D. Lal
Date Deposited: 11 Feb 2020 09:17
Last Modified: 29 Nov 2021 09:13
URI: http://nbrc.sciencecentral.in/id/eprint/602

Actions (login required)

View Item View Item